166 related articles for article (PubMed ID: 35507915)
1. Comparative Effectiveness and Safety of Milrinone and Levosimendan as Initial Inotrope Therapy in Patients With Acute Heart Failure With Renal Dysfunction.
Cui X; Wang Z; Dong X; Cheng Z; Zhang L; Mu Y; Huang X; Li Y; Hong Y; Han Y
J Cardiovasc Pharmacol; 2022 Jun; 79(6):781-790. PubMed ID: 35507915
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan and Continuous Outpatient Support With Inotropes in Patients With Advanced Heart Failure: A Single-Centre Descriptive Study.
Yeung T; Dagan M; Lankaputhra M; Cieslik L; Warner V; Leet A; Hare JL; Bergin P; Taylor AJ; Kaye DM; Patel HC
J Cardiovasc Pharmacol; 2022 Apr; 79(4):583-592. PubMed ID: 34983918
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis.
Zhang X; Wang Z; Zhang L; Zhao X; Han Y
J Cardiovasc Pharmacol; 2024 Jul; 84(1):92-100. PubMed ID: 38547524
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery.
Jothinath K; Balakrishnan S; Raju V; Menon S; Osborn J
Ann Card Anaesth; 2021; 24(2):217-223. PubMed ID: 33884979
[TBL] [Abstract][Full Text] [Related]
6. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
[TBL] [Abstract][Full Text] [Related]
7. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
8. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.
Milwidsky A; Frydman S; Laufer-Perl M; Sadeh B; Sapir O; Granot Y; Hochstadt A; Korotetski L; Ketchker L; Topilsky Y; Banai S; Havakuk O
ESC Heart Fail; 2022 Apr; 9(2):1487-1491. PubMed ID: 35083882
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
Thorlacius EM; Suominen PK; Wåhlander H; Keski-Nisula J; Vistnes M; Ricksten SE; Synnergren M; Romlin BS; Castellheim A
Pediatr Crit Care Med; 2019 Oct; 20(10):947-956. PubMed ID: 31274775
[TBL] [Abstract][Full Text] [Related]
11. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?
Angadi U; Westrope C; Chowdhry MF
Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):710-4. PubMed ID: 23832921
[TBL] [Abstract][Full Text] [Related]
12. Newer inotropes in pediatric heart failure.
Hoffman TM
J Cardiovasc Pharmacol; 2011 Aug; 58(2):121-5. PubMed ID: 21386708
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Levosimendan and Milrinone for ECLS Weaning in Patients After Cardiac Surgery-A Retrospective Before-and-After Study.
Jacky A; Rudiger A; Krüger B; Wilhelm MJ; Paal S; Seifert B; Spahn DR; Bettex D
J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2112-2119. PubMed ID: 29748076
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs.
Schwarte LA; Picker O; Bornstein SR; Fournell A; Scheeren TW
Crit Care Med; 2005 Jan; 33(1):135-42; discussion 246-7. PubMed ID: 15644660
[TBL] [Abstract][Full Text] [Related]
15. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system.
Antoniades C; Antonopoulos AS; Tousoulis D; Bakogiannis C; Stefanadi E; Stefanadis C
Curr Drug Metab; 2009 Feb; 10(2):95-103. PubMed ID: 19275545
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.
Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ
J Clin Pharmacol; 2002 Jan; 42(1):43-51. PubMed ID: 11808823
[TBL] [Abstract][Full Text] [Related]
20. Repetitive use of levosimendan in clinical practice: a case series.
Wawrzyniak M; Migaj J; Straburzyńska-Migaj E; Dudek M; Kałużna-Oleksy M
Cardiovasc J Afr; 2021 Nov-Dec 23; 32(6):339-342. PubMed ID: 33496720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
